Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20160722029027N7
IRCT20160722029027N7
Completed
Phase 2

Effect of gonadotropin-releasing hormone analogue (GnRh-a ) for triggering and luteal phase support in antagonist –in vitro fertillization cycles (IVF) in normal responders and comprission with standard protocol

Shahid Beheshti University of Medical Sciences0 sites72 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
72
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Women aged 20\-40 years normal respondering in IVF cycles
  • •Body mass index between 20\-30
  • •Fresh embryo transfer cycles
  • •Serum FSH of third menstrual day below 10 and absence of low ovarian response according bologna criteria

Exclusion Criteria

  • •Failed fertilization
  • •Sever endometriosis
  • •Decreased ovarian reserve.
  • •Unwillingness to continue
  • •Absence of good quality embryo
  • •Ovarian stimulation hyper stimulation (more than 18 mature follicles during ovarian stimulation )

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Ganirelix in insemination cycles of women with premature luteinizatioinfertilityintrauterine inseminationReproductive Health and Childbirth - Fertility including in vitro fertilisation
ACTRN12612000153819Mersin University114
Recruiting
Phase 3
Comparison of the effect of GnRH agonist administration with GNRH antagonist protocol on assisted reproductive methods in patients with reduced ovarian response.
IRCT20130603013566N10Vice chancellor for Research,Tabriz University Of Medical Sciences50
Recruiting
Phase 2
Women undergoing chemotherapy plus gonadotrophin-releasing hormone (GnRH) analouges compared with control to protect ovairan functioWomen of reproductive age receiving chemotherapyCancerReproductive Health and Childbirth - Fertility including in vitro fertilisationCancer - Breast
ACTRN12609001059257Ass. Prof. Dr. Eman Elgindy100
Completed
Not Applicable
Comparsion of effects of Gonadotropin Releasing Hormon Agonists and Antagonists in ART cycles in infertile patientsinfertility.female infertility
IRCT201109136626N3Tabriz University of Medical Sciences120
Completed
Not Applicable
GnRH-agonist trigger versus HCG trigger in cases of controlled ovaria
PACTR202001787868341faculty of medicine alexandria university300